Trial | NCT00370565  Report issue

Title

Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.
Efficacy And Safety Of Exubera (Inhaled Insulin) Therapy In Subjects With Type 2 Diabetes Mellitus Not Well Controlled With Combination Oral Agents: A Three-Month, Outpatient, Parallel Comparative Trial.

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    345
To assess the impact on glucose control by inhaled insulin alone or added to two oral anti-diabetic agents in patients with type 2 diabetes who are not well controlled on 2 oral anti-diabetic agents.
Study Started
Jun 30
1999
Study Completion
Sep 30
2000
Last Update
Feb 13
2007
Estimate

Drug Inhaled Human Insulin

Criteria 

Inclusion Criteria:

Type 2 Diabetes Mellitus as defined by American Diabetes Association (ADA) at least 1 year earlier.
Patients were required to have been treated with a stable oral agent regimen involving 2 antidiabetc medications: 1 insulin secretagogue (a sulfonylurea or replabinide) and 1 insulin sensitizer (a thiazolidinedione or metformin).

Exclusion Criteria:

Asthma, COPD
Smoking during the previous 6 months
No Results Posted